Inventor
SOKOLSKY ALEXANDER
US37 patents
⚠️ This page may combine multiple inventors who share the name “SOKOLSKY ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
36 patentsUS10251892B2Apr 9, 2019
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP33 citations98
US9708318B2Jul 18, 2017
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP44 citations98
US11173162B2Nov 16, 2021
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP22 citations94
US10934288B2Mar 2, 2021
Pyrazolopyridine compounds and uses thereof
INCYTE CORP13 citations94
US10745388B2Aug 18, 2020
Indazole compounds and uses thereof
INCYTE CORP24 citations94
US10632126B2Apr 28, 2020
Bicyclic heterocycles as FGFR4 inhibitors
INCYTE CORP27 citations94
US10435405B2Oct 8, 2019
Pyrazolopyridine compounds and uses thereof
INCYTE CORP23 citations94
US10280164B2May 7, 2019
Pyrazolopyridone compounds and uses thereof
INCYTE CORP24 citations94
US10266530B2Apr 23, 2019
Pyrazolopyridine compounds and uses thereof
INCYTE CORP24 citations94
US10800761B2Oct 13, 2020
Carboxamide compounds and uses thereof
INCYTE CORP15 citations93
US11492354B2Nov 8, 2022
Indazole compounds and uses thereof
INCYTE CORP8 citations86
US11406624B2Aug 9, 2022
Pyrazolopyridine compounds and uses thereof
INCYTE CORP9 citations86
US11242343B2Feb 8, 2022
Pyrazolopyridine compounds and uses thereof
INCYTE CORP12 citations86
US11066404B2Jul 20, 2021
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
INCYTE CORP13 citations86
US10752635B2Aug 25, 2020
Indazole compounds and uses thereof
INCYTE CORP16 citations86
US11542265B2Jan 3, 2023
Pyrazolopyrimidine compounds and uses thereof
INCYTE CORP8 citations85
US11299473B2Apr 12, 2022
Benzimidazole and indole compounds and uses thereof
INCYTE CORP10 citations85
US11014929B2May 25, 2021
Pyrazolopyrimidine compounds and uses thereof
INCYTE CORP12 citations85
US10899755B2Jan 26, 2021
Benzothiazole compounds and uses thereof
INCYTE CORP15 citations85
US10450296B2Oct 22, 2019
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP6 citations84
US9920032B2Mar 20, 2018
Heterocyclic compounds useful as pim kinase inhibitors
INCYTE CORP12 citations84
US12384778B2Aug 12, 2025
Pyrazolopyridine compounds and uses thereof
INCYTE CORP1 citations75
US11891388B2Feb 6, 2024
Pyrazolopyridine compounds and uses thereof
INCYTE CORP3 citations75
US11866432B2Jan 9, 2024
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
INCYTE CORP3 citations75
US11866426B2Jan 9, 2024
Benzothiazole compounds and uses thereof
INCYTE CORP3 citations74
US11731958B2Aug 22, 2023
Carboxamide compounds and uses thereof
INCYTE CORP4 citations74
US11795166B2Oct 24, 2023
Pyrazolopyridine compounds and uses thereof
INCYTE CORP2 citations73
US11384083B2Jul 12, 2022
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
INCYTE CORP6 citations73
US11919904B2Mar 5, 2024
Sulfonylamide compounds as CDK2 inhibitors
INCYTE CORP3 citations72
US11053215B2Jul 6, 2021
Heterocyclic compounds useful as Pim kinase inhibitors
INCYTE CORP1 citations63
US12516059B2Jan 6, 2026
Pyrazolopyridine compounds and uses thereof
INCYTE CORP0 citations62
US12466815B2Nov 11, 2025
Carboxamide compounds and uses thereof
INCYTE CORP0 citations62
US11939328B2Mar 26, 2024
Quinoline compounds as inhibitors of KRAS
INCYTE CORP0 citations61
US12378243B2Aug 5, 2025
Quinoline compounds as inhibitors of KRAS
INCYTE CORP0 citations56
US12331063B2Jun 17, 2025
Hetero-bicyclic inhibitors of KRAS
INCYTE CORP0 citations47
US11999752B2Jun 4, 2024
Vinyl imidazole compounds as inhibitors of KRAS
INCYTE CORP0 citations46